The Battle between Novel Corona Virus (COVID-19) and Human Being

Article Sidebar

PDF
Published: May 15, 2021
Keywords:
Coronavirus Outbreak Prevention Treatment Risk factors

Main Article Content

Muhammad Junaid
Medical College, Guangxi University
Zhong-quan Qi
Medical College, Guangxi University
Jianhua Yan
Medical College, Guangxi University
Shumaila Pervez
King Abdullah Teaching Hospitals
Chanyanan Somthawinpongsai
Rajapark Institute
Natamon Nanposri
Rajapark Institute

Abstract

Coronavirus is an enveloped virus that is diversely found in wildlife, domesticated animals, and humans. For the third time in many years coronavirus has crossed species to infect humans. The WHO on January 12, 2020, named the virus as 2019-nCoV and later on February 11, 2020, named as COVID-19. This novel agent belongs to the genus coronavirus having a high mutation rate. The objective of this review article is to describe the clinical features of the disease, its treatment, prevention, vaccine candidates, and their risk factors.

Article Details

How to Cite
Junaid, M. ., Qi, Z.- quan ., Yan, J. ., Pervez, S. ., Somthawinpongsai, C., & Nanposri, N. . (2021). The Battle between Novel Corona Virus (COVID-19) and Human Being. Rajapark Journal, 15(40), 1–14. Retrieved from https://so05.tci-thaijo.org/index.php/RJPJ/article/view/249135
Issue
Vol. 15 No. 40 (2021): May - June
Section
Academic Articles

Views and opinions appearing in the Journal it is the responsibility of the author of the article, and does not constitute the view and responsibility of the editorial team.

References

Almeida, J. D., Berry, D. M., Cunningham, C. H., Hamre, D., Hofstad, M. S., Mallucci, L., & Tyrrell, D. A. J. (1968). Coronaviruses. Nature, 220(5168), 650.

Assiri, A., Al-Tawfiq, J. A., Al-Rabeeah, A. A., Al-Rabiah, F. A., Al-Hajjar, S., Al-Barrak, A., & Memish, Z. A. (2013). Epidemiological, Demographic, and Clinical Characteristics of 47 cases of Middle East Respiratory Syndrome Coronavirus Disease from Saudi Arabia: A Descriptive Study. The Lancet infectious diseases, 13(9), 752-761.

Bai, Y., Yao, L., Wei, T., Tian, F., Jin, D. Y., Chen, L., & Wang, M. (2020). Presumed asymptomatic carrier transmission of COVID-19. Jama, 323(14), 1406-1407.

Bassetti, M., Vena, A., & Giacobbe, D. R. (2020). The Novel Chinese Coronavirus (2019‐nCoV) Infections: Challenges for fighting the Storm. Eur J Clin Invest. 50(3), e13209.

Cheever, F. S., Daniels, J. B., Pappenheimer, A. M., & Bailey, O. T. (1949). A Murine Virus (JHM) Causing Disseminated Encephalomyelitis with Extensive Destruction of Myelin: I. Isolation and Biological Properties of the Virus. The Journal of experimental medicine, 90(3), 181-194.

Chen, Z., Zhang, W., Lu, Y., Guo, C., Guo, Z., Liao, C., … & Lu, J. (2020). From SARS-CoV to Wuhan 2019-nCoV Outbreak: Similarity of Early Epidemic and Prediction of Future Trends. bioRxiv Preprint. DOI: https://doi.org/10.1101/2020.01.24.919241

Chu, H., Zhou, J., Wong, B. H. Y., Li, C., Cheng, Z. S., Lin, X., ... & Yuen, K. Y. (2014). Productive Replication of Middle East Respiratory Syndrome Coronavirus in Monocyte-Derived Dendritic Cells Modulates Innate Immune Response. Virology, 454, 197-205.

Cui, J., Li, F., & Shi, Z. L. (2019). Origin and Evolution of Pathogenic Coronaviruses. Nature Reviews Microbiology, 17(3), 181-192.

de Lemos, J. A., McGuire, D. K., & Drazner, M. H. (2003). B-type Natriuretic Peptide in Cardiovascular Disease. The Lancet, 362(9380), 316-322.

Drexler, J. F., Gloza-Rausch, F., Glende, J., Corman, V. M., Muth, D., Goettsche, M., ... & Drosten, C. (2010). Genomic Characterization of Severe Acute Respiratory Syndrome-Related Coronavirus in European Bats and Classification of Coronaviruses Based on Partial RNA-Dependent RNA Polymerase Gene Sequences. Journal of virology, 84(21), 11336-11349.

Gralinski, L. E., & Menachery, V. D. (2020). Return of the Coronavirus: 2019-nCoV. Viruses, 12(2), 135.

Han, Q., Lin, Q., Jin, S., & You, L. (2020). Coronavirus 2019-nCoV: A brief Perspective from the Front Line. Journal of Infection, 80(4), 373-377.

Hui, D. S., Azhar, E. I., Madani, T. A., Ntoumi, F., Kock, R., Dar, O., ... & Petersen, E. (2020). The Continuing 2019-nCoV Epidemic Threat of Novel Coronaviruses to Global Health—The Latest 2019 Novel Coronavirus Outbreak in Wuhan, China. International journal of infectious diseases, 91, 264-266.

Imai, N., Dorigatti, I., Cori, A., Donnelly, C., Riley, S., & Ferguson, N. (2020). Report 2: Estimating the Potential Total Number of Novel Coronavirus Cases in Wuhan City, China. Imperial College London. DOI: https://doi.org/10.25561/77150.

Kashid, R. V., Shidhore, A. A., Kazi, M. M., & Patil, S. (2020). Awareness of COVID-19 Amongst Undergraduate Dental Students in India–A Questionnaire Based Cross-sectional Study. Research Square. DOI: https://doi.org/10.21203/rs.3.rs-27183/v1

Kongchanagul, A., Suptawiwat, O., Boonarkart, C., Kitphati, R., Puthavathana, P., Uiprasertkul, M., & Auewarakul, P. (2011). Decreased Expression of Surfactant Protein D mRNA in Human Lungs in Fatal Cases of H5N1 Avian Influenza. Journal of Medical Virology, 83(8), 1410-1417.

Lambeir, A. M., Durinx, C., Scharpé, S., & De Meester, I. (2003). Dipeptidyl-Peptidase IV from Bench to Bedside: An Update on Structural Properties, Functions, and Clinical Aspects of the Enzyme DPP IV. Critical Reviews in Clinical Laboratory Sciences, 40(3), 209-294.

Lampert, P. W., Sims, J. K., & Kniazeff, A. J. (1973). Mechanism of Demyelination in JHM Virus Encephalomyelitis. Acta Neuropathologica, 24(1), 76-85.

Lee, N., Hui, D., Wu, A., Chan, P., Cameron, P., Joynt, G. M., ... & Sung, J. J. (2003). A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong. New England Journal of Medicine, 348(20), 1986-1994.

Littrup, P. J., Freeman-Gibb, L., Andea, A., White, M., Amerikia, K. C., Bouwman, D., ... & Sakr, W. (2005). Cryotherapy for Breast Fibroadenomas. Radiology, 234(1), 63-72.

Luk, H. K., Li, X., Fung, J., Lau, S. K., & Woo, P. C. (2019). Molecular Epidemiology, Evolution and Phylogeny of SARS Coronavirus. Infection, Genetics and Evolution, 71, 21-30.

Nannaware, P. S., & Mankar, S. D. (2020). REVIEW ON RECENT EMERGENCE OF NOVEL CORONA VIRUS. World Journal of Pharmaceutical Research, 9(6), 1-26.

Peiris, J. S. M., Lai, S. T., Poon, L. L. M., Guan, Y., Yam, L. Y. C., Lim, W., ... & SARS Study Group. (2003). Coronavirus as a Possible Cause of Severe Acute Respiratory Syndrome. The Lancet, 361(9366), 1319-1325.

Prince, M., Patel, V., Saxena, S., Maj, M., Maselko, J., Phillips, MR. & Rahman, A. (2007). Global Mental Health 1 - No Health Without Mental Health. Lancet, 370(9590), 859-877.

Ren-LL, W. Y., & Wu, Z. Q. (2020). Identification of a Novel Coronavirus Causing Severe Pneumonia in Human. Chin Med J, 133(9), 1015-1024.

Sahin, A. R., Erdogan, A., Agaoglu, P. M., Dineri, Y., Cakirci, A. Y., Senel, M. E., ... & Tasdogan, A. M. (2020). 2019 Novel Coronavirus (COVID-19) Outbreak: A Review of the Current Literature. EJMO, 4(1), 1-7.

Subissi, L., Posthuma, C. C., Collet, A., Zevenhoven-Dobbe, J. C., Gorbalenya, A. E., Decroly, E., ... & Imbert, I. (2014). One Severe Acute Respiratory Syndrome Coronavirus Protein Complex Integrates Processive RNA Polymerase and Exonuclease Activities. Proceedings of the National Academy of Sciences, 111(37), E3900-E3909.

Toots, M., Yoon, J. J., Cox, R. M., Hart, M., Sticher, Z. M., Makhsous, N., ... & Plemper, R. K. (2019). Characterization of Orally Efficacious Influenza Drug with High Resistance Barrier in Ferrets and Human Airway Epithelia. Science Translational Medicine, 11(515).

Wan, Y., Graham, R., Baric, R., & Li, F. (2020). Receptor Recognition by the Novel Coronavirus from Wuhan: An Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. J. Virol, 97(7), e00127-20. DOI: 10.1128/JVI.00127-20.

Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., ... & Xiao, G. (2020). Remdesivir and Chloroquine Effectively Inhibit the Recently Emerged Novel Ccoronavirus (2019-nCoV) in Vitro. Cell research, 30(3), 269-271.

Wang, W., Tang, J., & Wei, F. (2020). Updated Understanding of the Outbreak of 2019 Novel Coronavirus (2019‐nCoV) in Wuhan, China. Journal of Medical Virology, 92(4), 441-447.

Wang, Z., Chen, X., Lu, Y., Chen, F., & Zhang, W. (2020). Clinical Characteristics and Therapeutic Procedure for Four Cases with 2019 Novel Coronavirus Pneumonia Receiving Combined Chinese and Western Medicine Treatment. Bioscience Trends, 14(1), 64-68.

Woo, P. C., Huang, Y., Lau, S. K., & Yuen, K. Y. (2010). Coronavirus Genomics and Bioinformatics Analysis. Viruses, 2(8), 1804-1820.

World Health Organization (WHO). (2020a). DRAFT Landscape of COVID-19 Candidate Vaccines July 14, 2020. World Health Organization.

World Health Organization (WHO). (2020b). Novel Coronavirus (2019-nCoV) Situation Reports. World Health Organization.

Yang, X., Yu, Y., Xu, J., Shu, H., Liu, H., Wu, Y., ... & Shang, Y. (2020). Clinical Course and Outcomes of Critically ill Patients with SARS-CoV-2 Pneumonia in Wuhan, China: A Single-Centered, Retrospective, Observational Study. The Lancet Respiratory Medicine, 8(5), 475-481.

Yin, Y., & Wunderink, R. G. (2018). MERS, SARS and Other Coronaviruses as Causes of Pneumonia. Respirology, 23(2), 130-137.

Zaki, A. M., Van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D., & Fouchier, R. A. (2012). Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia. New England Journal of Medicine, 367(19), 1814-1820.

Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., ... & Lu, R. others. (2020). A Novel Coronavirus from Patients with Pneumonia in China, 2019. The New England Journal of Medicine, 382, 727-733. DOI: 10.1056/NEJMoa2001017